• Ticker

    Advertisement Find a Broker - Visit the DailyFinance Broker Center
DJIA 12,454.83 -74.92 -0.60%
NASDAQ 2,837.53 -1.85 -0.07%
S&P 500 1,317.82 -2.86 -0.22%

$13.70 -$0.07 (-0.51%)

REAL-TIME: Last trade at

Emergent BioSolutions

NYSE:EBS

Jump to this page for:

Related Resources

Emergent BioSolutions to Present at Jefferies 2012 Global Healthcare Conference

5/22/2012 by StockWatch

Emergent BioSolutions to Present at Jefferies 2012 Global Healthcare Conference

5/22/2012 by Business Wire

Emergent BioSolutions approves $35 million stock buyback

5/21/2012 by Baltimore Business Journal - Baltimore MD

Emergent BioSolutions Announces Stock Repurchase Program

5/21/2012 by PharmiWeb.com - UK

Emergent BioSolutions authorizes stock buyback program of up to $35M

5/21/2012 by Theflyonthewall.com

Emergent BioSolutions Announces Stock Repurchase Program

5/21/2012 by Business Wire

Emergent gets FDA approval for modified vaccine dosing

5/18/2012 by Washington Business Journal - Washington DC

Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses

5/18/2012 by BioSpace

Emergent BioSolutions management to meet with JPMorgan

5/18/2012 by Theflyonthewall.com

Emergent BioSolutions (EBS) Receives FDA Approval for BioThrax Treatment

5/17/2012 by StreetInsider.com

Emergent BioSolutions receives FDA approval for BioThrax

5/17/2012 by Theflyonthewall.com

Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses

5/17/2012 by Business Wire

Emergent BioSolutions' CEO Hosts Annual Shareholder Meeting Conference (Transcript)

5/17/2012 by Seeking Alpha

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday, May 17, 2012 at 9:00 AM Eastern; Webcast Will Be Available

5/10/2012 by PharmiWeb.com - UK

Emergent BioSolutions to Hold Annual Meeting of Stockholders Thursday, May 17, 2012 at 9:00 AM Eastern; Webcast Will Be Available

5/10/2012 by Business Wire

Emergent BioSolutions Reports Financial Results for First Quarter 2012

5/4/2012 by PharmiWeb.com - UK

Emergent BioSolutions CEOs Discuss 1Q 2012 Results - Earnings Call Transcript

5/4/2012 by Seeking Alpha

Emergent Biosolutions (EBS) Files $180M Mixed Shelf; 3M Common for Shareholders

5/3/2012 by StreetInsider.com

Emergent BioSolutions files to sell 3M shares of common stock for holders

5/3/2012 by Theflyonthewall.com

Emergent BioSolutions files $180M mixed securities shelf

5/3/2012 by Theflyonthewall.com

Emergent Biosolutions (EBS) Tops Q1 EPS by 13c; Guides Q2 Sales

5/3/2012 by StreetInsider.com

Emergent reaffirms 2012 revenue outlook $280M-$300M, consensus $290.54M

5/3/2012 by Theflyonthewall.com

Emergent BioSolutions reports Q1 EPS (2c), consensus (15c)

5/3/2012 by Theflyonthewall.com

Emergent BioSolutions sees Q2 revenue $70M-$80M, consensus $76.64M

5/3/2012 by Theflyonthewall.com

HGSI Could Sink Without New Pipeline Drug Success

5/2/2012 by Seeking Alpha

Emergent BioSolutions Executive Chairman Fuad El-Hibri Named Tech Council of Maryland’s Executive of the Year

4/27/2012 by PharmiWeb.com - UK

Emergent BioSolutions Executive Chairman Fuad El-Hibri Named Tech Council of Maryland's Executive of the Year

4/26/2012 by StockHouse

Emergent BioSolutions Executive Chairman Fuad El-Hibri Named Tech Council of Maryland’s Executive of the Year

4/26/2012 by Business Wire

NATO Emerging Security Challenges Division Partners with Emergent BioSolutions to Host Biopreparedness Workshop at the Counter Terror Expo in London

4/26/2012 by PharmiWeb.com - UK

NATO Emerging Security Challenges Division Partners with Emergent BioSolutions to Host Biopreparedness Workshop at the Counter Terror Expo in London

4/26/2012 by Business Wire

Emergent BioSolutions plans $108M upgrade in Lansing

4/24/2012 by The Detroit News - Detroit MI

HGSI Will Take Massive Hit If Albiglutide, Darapladib Fail

4/13/2012 by Seeking Alpha

Emergent BioSolutions to Release First Quarter 2012 Financial Results and Conduct a Conference Call on May 3, 2012

4/12/2012 by PharmiWeb.com - UK

Emergent BioSolutions to Release First Quarter 2012 Financial Results and Conduct a Conference Call on May 3, 2012

4/12/2012 by Business Wire

Emergent BioSolutions Receives NIAID Grant to Support Tuberculosis Vaccine Candidate

3/23/2012 by PharmiWeb.com - UK

Emergent BioSolutions Receives NIAID Grant to Support Tuberculosis Vaccine Candidate

3/22/2012 by StockHouse

Emergent BioSolutions Receives NIAID Grant to Support Tuberculosis Vaccine Candidate

3/22/2012 by Business Wire

Emergent BioSolutions' Management Presents at Lazard Capital Markets Healthcare Conference 2011 (Transcript)

3/14/2012 by Seeking Alpha

Emergent BioSolutions Management Presents at JPMorgan SMid Cap Conference (Transcript)

3/13/2012 by Seeking Alpha

Emergent Biosolutions (EBS) Tops Q4 EPS by 6c; Reaffirms FY12 Revs

3/9/2012 by StreetInsider.com
See More Articles...